Development and validation of a prognostic model for patients with advanced lung cancer treated with the immune checkpoint inhibitor atezolizumab

Ashley Hopkins, Ganessan Kichenadasse, Elizabeth Garrett-Meyer, Christos Karapetis, Andrew Rowland, Michael J Sorich

Research output: Contribution to journal › Article › peer-review

34 Citations (Scopus)
115 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Development and validation of a prognostic model for patients with advanced lung cancer treated with the immune checkpoint inhibitor atezolizumab'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology